Todd Chappell
Plus aucun poste en cours
Fortune : - $ au 30/04/2024
Profil
Todd Chappell's former jobs include being the Chief Executive Officer at Crystalline Medical, Inc., Rasio Therapeutics, Inc., and Perceptive Navigation LLC.
He also held positions as the Executive Director-New Products at CombinatoRx, Inc. and Vice President-Operations at TetraLogic Research & Development Corp.
Additionally, he worked as the Vice President-Operations at Shape Pharmaceuticals, Inc. .
Mr. Chappell's education history includes an undergraduate degree from the University of California, Los Angeles and an MBA from the Questrom School of Business.
Mr. Chappell's current jobs are as a Consultant at Biohealth Innovation, Inc. and as the Chief Operating Officer at Korro Bio, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 03/11/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Todd Chappell
| Sociétés | Poste | Début |
|---|---|---|
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 20/01/2014 |
Anciens postes connus de Todd Chappell
| Sociétés | Poste | Fin |
|---|---|---|
| Rasio Therapeutics, Inc. | Directeur Général | 01/03/2021 |
Crystalline Medical, Inc.
 Crystalline Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Crystalline Medical, Inc. develops solutions for the rapidly growing image-guided surgery market. Its technology provides for a forward-viewing, image-guided interventional probe that seeks to significantly improve both the safety and efficacy of millions of procedures per year in the areas of interventional radiology, cardiology, interventional oncology, pulmonology, and urology. The company was founded by Theodore P. Abraham in 2012 and is headquartered in Baltimore, MD. | Directeur Général | - |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Corporate Officer/Principal | - |
Formation de Todd Chappell
| University of California, Los Angeles | Undergraduate Degree |
| Questrom School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
TetraLogic Research & Development Corp.
 TetraLogic Research & Development Corp. BiotechnologyHealth Technology TetraLogic Research & Development Corp. develops SHP-141 topical HDAC inhibitor clinical development for cutaneous T cell lymphoma. Its currently conducting a randomized, double-blind, placebo controlled, phase 1b study, to evaluate the safety and tolerability of SHP-141 in patients with stage 1A, 1B or 2A CTCL. The company was founded by James E. Bradner and Ralph Mazitschek in 2008 and is headquartered in Cambridge, MA. | Health Technology |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Finance |
Crystalline Medical, Inc.
Crystalline Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Crystalline Medical, Inc. develops solutions for the rapidly growing image-guided surgery market. Its technology provides for a forward-viewing, image-guided interventional probe that seeks to significantly improve both the safety and efficacy of millions of procedures per year in the areas of interventional radiology, cardiology, interventional oncology, pulmonology, and urology. The company was founded by Theodore P. Abraham in 2012 and is headquartered in Baltimore, MD. | Electronic Technology |
| Rasio Therapeutics, Inc. |
